AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. WAKAMOTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Net income margin (%)

WAKAMOTO PHARMACEUTICAL CO.,LTD.【JP:4512】

Market cap
¥11.6B
P/E ratio
58x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 20250.8-41.25%
Mar 31, 20241.4-11.80%
Mar 31, 20231.6-43.90%
Mar 31, 20222.8-142.06%
Mar 31, 2021-6.8-55.41%
Mar 31, 2020-15.2+798.99%
Mar 31, 2019-1.7-246.08%
Mar 31, 20181.2+32.08%
Mar 31, 20170.9+376.97%
Mar 31, 20160.2-76.37%
Mar 31, 20150.8-90.40%
Mar 31, 20148.1+343.08%
Mar 31, 20131.8-242.20%
Mar 31, 2012-1.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)